A Phase 2/3 Study to Evaluate the Efficacy and Safety of Tinlarebant in Subjects With Stargardt Disease
Clinical trial NCT06388083 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06388083
- Sponsor
- Belite Bio, Inc
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-31
- Primary completion
- 2028-02-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.